Clinical Trial Update: Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients [Phase 4]

View source ↗

Summary

Phase 4 trial investigating optimization of therapeutic human serum albumin infusion in selected critically ill patients; terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoalbuminaemia
• Shock
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Human Serum Albumin (human serum albumin)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Shock, Systemic Inflammatory Response Syndrome (SIRS) | Phase 4 | Status: TERMINATED